Manufacturer Drug Transparency Guidelines, Reporting Information and Templates

Drug Manufacturer Registration Template

Reporting Instructions & Template ~Drug Manufacturer Report-Diabetes and Over $40

NRS 439B.635 – Manufacturers of certain drugs to prepare and submit a report on or before April 1st annually. This refers to Nevada Drug Lists #2 and #4.

Reporting Instructions & Templates ~ Drug Manufacturer Significant Price Increase Report

NRS 439B.640 – Manufacturers of certain drugs that have undergone a significant price increase to submit report on or before April 1st annually. This refers to Nevada Drug Lists #3 and #4.

Reporting Instructions & Template ~ Pharmaceutical Sales Representatives Registry

NRS 439B.660 – Manufacturers required to provide a complete list of pharmaceutical sales representatives active in Nevada, on or before January 15th annually. A person who is not included on a current list submitted pursuant to subsection 1 shall not market prescription drugs on behalf of a manufacturer.

 

Contact Us


For all report submissions or technical assistance, please use the following email:

DrugTransparency@dhhs.nv.gov


Nevada Department of Health & Human Services-Drug Transparency Program

(775) 684-4255


Mailing Address:
DHHS Drug Transparency Program, c/o Director’s Office
400 West King Street, Suite 300
Carson City, NV 89703


    Resources & Information